UM toxicologists work on chemical safety tests
Scientists will be joining forces with the cosmetic industry over the next six years to produce tests that can measure the toxicity of chemicals. Since 2013, animals may no longer be used in the development of cosmetic products. The European Commission has reserved 30 million euros for the EUToxRisk project, 1.5 million of which will go to Maastricht University. UM, a world leader in the field of toxicogenomics, will be working on the RNA sequencing part of the project. Leiden University will be leading the consortium.
Since 2013 animals may no longer be used to test the safety of chemical substances in the development of cosmetic products. This ban has hampered progress in the sector, especially when it comes to innovation in cosmetics – for example, creams that are absorbed into the skin to reduce wrinkles and contain substances that end up in the human body.
There have been projects before that were meant to find alternative testing methods, unfortunately with little result. "It's going to work this time", says Jos Kleinjans, professor of Environmental Health Science at UM, "because the funding is now provided by a single party, it's one large consortium conducting the project, and the collaboration between public and private parties is better organised." Large companies like L’Oreal, BASF, Hoffmann-La Roche and Unilever are among the list of participants. "Together we aim to create usable tests within six years, developed using a range of new fit-for-purpose technologies", Kleinjans adds.
UM's contribution will involve the "sequencing" of RNA. "In short, it's a technology that allows us to study the human genome's response to harmful substances in greater detail. We can go deeper into cells than ever before, and pick up smaller signals more reliably." Kleinjans's research group introduced the technology to the field of toxicology in collaboration with the American Food and Drug Administration. The team plans to use RNA sequencing to measure the harmful effect of many chemical substances on the human genome.
The consortium aims to develop usable testing methods for the pharmaceutical, chemical and cosmetics industries. "We hope to create a kind of classification system for the tens of thousands of different chemicals used around the world. Our hypothesis is that if two chemical substances have the same chemical structure, they will also have the same safety profile. If that is the case, we can cover a great deal of ground. Naturally, this hope is based on science, but we'll be conducting plenty of solid research over the next few years to test whether this hope can hold up under closer scrutiny", Kleinjans resolves.
Also read
-
EU grant to co-create pioneering research in ethical AI for healthcare
Prof. Dr. Dominik Mahr and Prof. Dr. Gaby Odekerken-Schröder from the School of Business and Economics (SBE) are part of a consortium that has been awarded a €2.3 million Marie Skłodowska-Curie Actions training network grant for their project JustHealth.
This project aims to create a decolonised...
-
Esther Heuts - Director of Education for Medicine
As a clinician, educationalist and mother of three teenagers, Esther Heuts understands better than anyone the constantly evolving world of students and doctors. From this academic year, Esther will draw on that experience in her new role as Director of Education for Medicine.
-
Prof. Dr. Wim Gijselaers receives prestigious AERA Distinguished Career Award
Prof. Dr. Wim Gijselaers has received the Distinguished Career Award from AERA Division I, recognising his pioneering research, mentorship and decades of leadership in education in the professions.
